Compare Fortinet Inc (FTNT) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fortinet Inc vs Hinge Health Inc. Class A Common Stock — how do they compare? Fortinet Inc trades at $179.99 (market cap $135.04B), while Hinge Health Inc. Class A Common Stock trades at $103.52 (market cap $8.47B). The key difference: Fortinet Inc is far larger — about 15.9× Hinge Health Inc. Class A Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Fortinet Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fortinet Inc for 72 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| FTNT | HNGE | |
|---|---|---|
Market Cap | $135.04B | $8.47B |
Volume | 3,955,126 | 1,624,526 |
Sector | Technology | Health |
52-Week High | $194.75 | $105.14 |
52-Week Low | $75.23 | $31.17 |
Typical Hold Time | 72 Days | 0 Days |
Enterprise Value | $131.47B | $8.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fortinet (FTNT) trades at $190.76, down 1.13% on the day, but maintains a bullish technical trend with strong support near $191. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $0.90 surpassing the $0.746 estimate. Revenue growth is solid, climbing to $6.8B in 2025, though valuation multiples like a P/E of 65.04 suggest a premium pricing. Positive sentiment is fueled by AI-driven cybersecurity demand and raised 2026 guidance.
Outlook: Fortinet's leadership in converged networking security and ASIC-powered firewalls supports continued market share gains. Investment appeal hinges on sustained high growth to justify elevated valuations. Key risks include competitive pressures and execution challenges in a dynamic tech landscape. Analyst consensus is mixed with a $160.24 price target, indicating potential downside from current levels amid growth expectations.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fortinet Inc
Fortinet is a cybersecurity vendor that sells products, support, and services to small and midsize businesses, enterprises, and government entities. Its products include unified threat management appliances, firewalls, network security, and its security platform, Security Fabric. Services revenue is primarily from FortiGuard security subscriptions and FortiCare technical support. At the end of 2021, products were 38% of revenue and services were 62% of sales. The California-based company sells products worldwide.
Read more on FTNT →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
